Cash flow Cigna

Stocks

CI

US1255231003

Managed Healthcare

Market Closed - NYSE Other stock markets 00:00:02 18/07/2026 +04			After hours 04:00:00
281.45 ^USD	-0.84%		282.42	+0.34%

07-15	Simpler prior authorizations, digital tools boost trust in insurers, Aetna president says	RE
07-14	DOJ Expands Antitrust Probe Into Claritev	MT

9b2ee460ff7.CkV0SMMbwIUsjbNVUT2f45PhZ9RgrWqQsMDvWt7ap_s.eCcSeIIqrukbxsttJlnJl-eDVu0k2x7f8e2_Iu2S3so8NTwsolWZ0hzv-g

Published financial data: CIGNA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	173B	179B	194B	246B	274B
Gain (Loss) on Sale of Investment, Total (Rev)	-	-	-	-	-
Interest And Invest. Income (Rev)	1.55B	1.16B	1.17B	973M	1.05B
Total Revenues	174B	181B	195B	247B	275B
Cost of Goods Sold, Total	151B	157B	170B	221B	249B
Gross Profit	22.96B	23.48B	25.18B	25.96B	25.56B
Selling General & Admin Expenses, Total	12.81B	13.12B	14.37B	14.57B	13.56B
Stock-Based Compensation (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	2B	1.88B	1.82B	1.7B	1.74B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	14.81B	15B	16.19B	16.27B	15.3B
Operating Income	8.16B	8.48B	8.99B	9.69B	10.26B
Interest Expense, Total	-1.12B	-1.16B	-1.4B	-1.5B	-1.4B
Net Interest Expenses	-1.12B	-1.16B	-1.4B	-1.5B	-1.4B
Other Non Operating Income (Expenses)	-	-	-	65M	-8M
EBT, Excl. Unusual Items	7.04B	7.32B	7.59B	8.26B	8.85B
Restructuring Charges	-168M	-22M	-252M	-	-749M
Merger & Related Restructuring Charges	-169M	-135M	-45M	-275M	-327M
Gain (Loss) On Sale Of Investments	196M	-495M	-78M	-2.74B	-24M
Gain (Loss) On Sale Of Assets	-	1.66B	-1.5B	24M	13M
Legal Settlements	27M	28M	-201M	-	17M
Other Unusual Items	-141M	-	-	-	-
EBT, Incl. Unusual Items	6.78B	8.35B	5.51B	5.27B	7.78B
Income Tax Expense	1.37B	1.61B	141M	1.49B	1.49B
Earnings From Continuing Operations	5.42B	6.75B	5.37B	3.78B	6.29B
Net Income to Company	5.42B	6.75B	5.37B	3.78B	6.29B
Minority Interest	-50M	-78M	-208M	-344M	-331M
Net Income - (IS)	5.36B	6.67B	5.16B	3.43B	5.96B
Net Income to Common Incl Extra Items	5.36B	6.67B	5.16B	3.43B	5.96B
Net Income to Common Excl. Extra Items	5.36B	6.67B	5.16B	3.43B	5.96B
Per Share Items
Net EPS - Basic	15.87	21.54	17.57	12.25	22.33
Basic EPS - Continuing Operations	15.87	21.54	17.57	12.25	22.33
Basic Weighted Average Shares Outstanding	338M	310M	294M	280M	267M
Net EPS - Diluted	15.73	21.3	17.39	12.12	22.18
Diluted EPS - Continuing Operations	15.73	21.3	17.39	12.12	22.18
Diluted Weighted Average Shares Outstanding	341M	313M	297M	283M	269M
Normalized Basic EPS	12.87	14.52	15.43	17.18	19.5
Normalized Diluted EPS	12.75	14.35	15.27	17.01	19.37
Dividend Per Share	4	4.48	4.92	5.6	6.04
Payout Ratio	25	20.76	28.08	45.63	27.04
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	9.96B	10.34B	10.8B	11.45B	12.05B
EBITA	9.7B	10.08B	10.54B	11.2B	11.81B
EBIT	8.16B	8.48B	8.99B	9.69B	10.26B
EBITDAR	10.17B	10.5B	10.95B	-	-
Total Revenues (As Reported)	174B	181B	195B	247B	275B
Effective Tax Rate - (Ratio)	20.16	19.24	2.56	28.3	19.19
Current Domestic Taxes	1.38B	1.87B	1.64B	1.34B	976M
Current Foreign Taxes	207M	219M	161M	248M	191M
Total Current Taxes	1.59B	2.09B	1.8B	1.59B	1.17B
Deferred Domestic Taxes	-289M	-452M	-613M	-159M	-121M
Deferred Foreign Taxes	69M	-28M	-1.05B	64M	447M
Total Deferred Taxes	-220M	-480M	-1.66B	-95M	326M
Normalized Net Income	4.35B	4.49B	4.53B	4.82B	5.2B
Interest on Long-Term Debt	2M	2M	4M	-	-
Non-Cash Pension Expense	-55M	-43M	52M	-13M	2M
Supplemental Operating Expense Items
Net Rental Expense, Total	209M	165M	153M	-	-
Imputed Operating Lease Interest Expense	55.17M	46.65M	54.46M	-	-
Imputed Operating Lease Depreciation	154M	118M	98.54M	-	-
Stock-Based Comp., SG&A Exp. (Total)	183M	167M	220M	238M	203M
Stock-Based Comp., Other (Total)	85M	97M	66M	70M	88M
Total Stock-Based Compensation	268M	264M	286M	308M	291M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.08B	5.92B	7.82B	7.55B	7.68B
Short Term Investments	920M	905M	925M	665M	1.06B
Total Cash And Short Term Investments	6B	6.83B	8.75B	8.22B	8.73B
Accounts Receivable, Total	14.62B	16.97B	17.72B	24.06B	28.53B
Other Receivables	585M	422M	183M	321M	359M
Total Receivables	15.2B	17.39B	17.9B	24.39B	28.89B
Inventory	3.72B	4.78B	5.64B	6.69B	7.34B
Other Current Assets, Total	11.21B	1.12B	5.05B	9.58B	2.86B
Total Current Assets	36.13B	30.12B	37.35B	48.87B	47.81B
Gross Property Plant And Equipment	3.32B	2.63B	2.65B	2.12B	2.08B
Accumulated Depreciation	-1.65B	-1.33B	-1.4B	-1.29B	-1.2B
Net Property Plant And Equipment	1.66B	1.3B	1.25B	828M	877M
Long-term Investments	18.4B	17.14B	18.14B	15.13B	18.47B
Goodwill	45.81B	45.81B	44.26B	44.37B	44.92B
Other Intangibles, Total	36.61B	35.34B	33.76B	32.24B	31.33B
Deferred Tax Assets Long-Term	-	-	2.29B	954M	459M
Deferred Charges Long-Term	677M	-	-	-	-
Other Long-Term Assets, Total	15.6B	14.22B	15.72B	13.49B	14.04B
Total Assets	155B	144B	153B	156B	158B
Liabilities
Accounts Payable, Total	21.96B	24.84B	28.37B	37.76B	40.99B
Accrued Expenses, Total	7.16B	7.89B	9.65B	6.49B	6.71B
Short-term Borrowings	2.03B	-	1.24B	880M	-
Current Portion of Long-Term Debt	495M	2.96B	1.5B	2.11B	549M
Current Portion of Leases	182M	147M	147M	43M	43M
Unearned Revenue Current, Total	-	576M	846M	753M	822M
Other Current Liabilities	11.74B	4.81B	6.97B	9.94B	7.23B
Total Current Liabilities	43.57B	41.23B	48.72B	57.98B	56.34B
Long-Term Debt	31.1B	28.03B	28.09B	28.9B	30.8B
Long-Term Leases	464M	412M	406M	41M	68M
Unearned Revenue Non Current	-	22M	22M	31M	40M
Pension & Other Post Retirement Benefits	363M	-	-	-	-
Deferred Tax Liability Non Current	8.35B	7.75B	7.17B	6.98B	7.14B
Other Non Current Liabilities	23.86B	21.53B	22B	20.72B	21.65B
Total Liabilities	108B	98.98B	106B	115B	116B
Common Stock, Total	4M	4M	4M	4M	4M
Additional Paid In Capital	29.57B	30.23B	30.67B	31.29B	31.79B
Retained Earnings	32.59B	37.87B	41.65B	43.52B	47.86B
Treasury Stock	-14.18B	-21.84B	-24.24B	-31.44B	-35.14B
Comprehensive Income and Other	-884M	-1.4B	-1.86B	-2.34B	-2.81B
Total Common Equity	47.11B	44.87B	46.22B	41.03B	41.71B
Minority Interest	72M	79M	128M	210M	161M
Total Equity	47.18B	44.95B	46.35B	41.24B	41.87B
Total Liabilities And Equity	155B	144B	153B	156B	158B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	321M	297M	292M	274M	264M
ECS Total Common Shares Outstanding	323M	299M	293M	274M	263M
Book Value / Share	145.88	150.24	158.03	149.87	158.33
Tangible Book Value	-35.31B	-36.28B	-31.79B	-35.58B	-34.54B
Tangible Book Value Per Share	-109.33	-121.47	-108.7	-129.95	-131.12
Total Debt	34.26B	31.55B	31.38B	31.97B	31.46B
Net Debt	28.26B	24.72B	22.63B	23.76B	22.73B
Debt Equivalent of Unfunded Proj. Benefit Obligation	377M	-238M	-204M	-211M	-218M
Debt Equivalent Oper. Leases	1.67B	1.32B	1.22B	-	-
Minority Interest, Total (Incl. Fin. Div)	72M	79M	128M	210M	161M
Equity Method Investments, Total	-	900M	200M	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Full Time Employees	73.7K	69.16K	70.32K	71.3K	65.67K
Part Time Employees	-	2.14K	2.18K	2.2K	2.03K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.25B	336M	-	84M	199M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.36B	6.67B	5.16B	3.43B	5.96B
Depreciation & Amortization - CF	253M	251M	260M	248M	239M
Amortization of Goodwill and Intangible Assets - (CF)	1.55B	1.61B	1.55B	1.51B	1.55B
Depreciation & Amortization, Total	1.8B	1.86B	1.81B	1.75B	1.79B
Amortization of Deferred Charges, Total - (CF)	1.12B	1.08B	1.22B	1.02B	987M
(Gain) Loss From Sale Of Asset	-	-1.66B	1.5B	-24M	-13M
(Gain) Loss on Sale of Investments - (CF)	-196M	495M	78M	2.74B	24M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-29M	-402M	-1.45B	249M	657M
Change In Accounts Receivable	-2.84B	-2.24B	-1.66B	-7.37B	-4.63B
Change In Inventories	-557M	-1.06B	-868M	-1.03B	-646M
Change In Accounts Payable	1.88B	3.33B	5.51B	9.9B	4.66B
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	644M	578M	508M	-302M	812M
Cash from Operations	7.19B	8.66B	11.81B	10.36B	9.6B
Capital Expenditure	-1.15B	-1.3B	-1.57B	-1.41B	-1.21B
Cash Acquisitions	-1.83B	-	-447M	-131M	-597M
Divestitures	-61M	4.84B	13M	521M	2.98B
Investment in Marketable and Equity Securities, Total	-513M	-209M	-2.9B	-248M	-4.55B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-147M	-63M	68M	134M	106M
Other Investing Activities, Total	97M	-170M	-332M	-972M	-1.14B
Cash from Investing	-3.61B	3.1B	-5.17B	-2.1B	-4.41B
Short Term Debt Issued, Total	975M	-	1.2B	-	-
Long-Term Debt Issued, Total	4.26B	-	1.49B	4.46B	6.46B
Total Debt Issued	5.24B	-	2.69B	4.46B	6.46B
Short Term Debt Repaid, Total	-	-2.06B	-	-402M	-927M
Long-Term Debt Repaid, Total	-4.58B	-500M	-2.97B	-3B	-6.2B
Total Debt Repaid	-4.58B	-2.56B	-2.97B	-3.4B	-7.12B
Issuance of Common Stock	326M	389M	187M	305M	203M
Repurchase of Common Stock	-7.74B	-7.61B	-2.28B	-7.03B	-3.62B
Common Dividends Paid	-1.34B	-1.38B	-1.45B	-1.57B	-1.61B
Common & Preferred Stock Dividends Paid	-1.34B	-1.38B	-1.45B	-1.57B	-1.61B
Other Financing Activities, Total	-112M	-79M	-469M	-411M	-725M
Cash from Financing	-8.21B	-11.24B	-4.29B	-7.65B	-6.42B
Foreign Exchange Rate Adjustments	-65M	-86M	16M	-20M	32M
Miscellaneous Cash Flow Adjustments	-425M	-	-467M	-1.34B	-
Net Change in Cash	-5.12B	428M	1.89B	-745M	-1.2B
Supplemental Items
Cash Interest Paid	1.25B	1.23B	1.33B	1.34B	1.35B
Cash Income Tax Paid (Refund)	2.24B	1.85B	1.47B	898M	399M
Levered Free Cash Flow	960M	10.57B	8.9B	3.75B	9.77B
Unlevered Free Cash Flow	1.66B	11.3B	9.77B	4.69B	10.64B
Change In Net Working Capital	5.48B	-4.1B	-2.41B	3.05B	-2.38B
Net Debt Issued / Repaid	657M	-2.56B	-278M	1.06B	-667M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.29	3.55	3.79	3.93	4.09
Return on Total Capital	6.16	6.71	7.29	8.05	8.75
Return On Equity %	11.1	14.64	11.79	8.63	15.13
Return on Common Equity	11.01	14.5	11.36	7.87	14.4
Margin Analysis
Gross Profit Margin %	13.19	13	12.89	10.51	9.3
SG&A Margin	7.36	7.27	7.36	5.9	4.93
EBITDA Margin %	5.72	5.73	5.53	4.63	4.38
EBITA Margin %	5.57	5.59	5.4	4.53	4.3
EBIT Margin %	4.69	4.7	4.6	3.92	3.73
Income From Continuing Operations Margin %	3.11	3.74	2.75	1.53	2.29
Net Income Margin %	3.08	3.69	2.64	1.39	2.17
Net Avail. For Common Margin %	3.08	3.69	2.64	1.39	2.17
Normalized Net Income Margin	2.5	2.49	2.32	1.95	1.89
Levered Free Cash Flow Margin	0.55	5.86	4.56	1.52	3.55
Unlevered Free Cash Flow Margin	0.95	6.26	5	1.9	3.87
Asset Turnover
Asset Turnover	1.12	1.21	1.32	1.6	1.75
Fixed Assets Turnover	102.16	121.76	153.27	289.88	322.46
Receivables Turnover (Average Receivables)	12.97	11.36	11.19	11.86	10.41
Inventory Turnover (Average Inventory)	43.88	36.95	32.64	35.85	35.54
Short Term Liquidity
Current Ratio	0.83	0.73	0.77	0.84	0.85
Quick Ratio	0.49	0.59	0.55	0.56	0.67
Operating Cash Flow to Current Liabilities	0.17	0.21	0.24	0.18	0.17
Days Sales Outstanding (Average Receivables)	28.15	32.14	32.62	30.86	35.05
Days Outstanding Inventory (Average Inventory)	8.32	9.88	11.18	10.21	10.27
Average Days Payable Outstanding	49.08	54.03	56.81	54.46	57.49
Cash Conversion Cycle (Average Days)	-12.61	-12.02	-13	-13.39	-12.17
Long Term Solvency
Total Debt/Equity	72.62	70.19	67.69	77.52	75.14
Total Debt / Total Capital	42.07	41.24	40.37	43.67	42.9
LT Debt/Equity	66.89	63.28	61.48	70.16	73.72
Long-Term Debt / Total Capital	38.75	37.18	36.66	39.52	42.09
Total Liabilities / Total Assets	69.54	68.77	69.66	73.54	73.48
EBIT / Interest Expense	7.29	7.29	6.42	6.46	7.33
EBITDA / Interest Expense	9.08	9.03	7.82	7.63	8.6
(EBITDA - Capex) / Interest Expense	8.05	7.91	6.7	6.69	7.74
Total Debt / EBITDA	3.37	3.01	2.86	2.79	2.61
Net Debt / EBITDA	2.78	2.35	2.07	2.08	1.89
Total Debt / (EBITDA - Capex)	3.8	3.43	3.34	3.18	2.9
Net Debt / (EBITDA - Capex)	3.14	2.69	2.41	2.37	2.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.53	3.7	8.17	26.56	11.24
Gross Profit, 1 Yr. Growth %	-5.14	2.23	7.14	3.13	-1.56
EBITDA, 1 Yr. Growth %	-3.96	3.8	4.14	5.53	5.25
EBITA, 1 Yr. Growth %	-3.84	3.92	4.15	5.78	5.45
EBIT, 1 Yr. Growth %	-4.78	3.95	5.57	7.28	5.85
Earnings From Cont. Operations, 1 Yr. Growth %	-36.21	24.58	-20.79	-29.67	66.44
Net Income, 1 Yr. Growth %	-36.57	24.29	-22.97	-33.5	73.47
Normalized Net Income, 1 Yr. Growth %	-2.66	3.35	0.4	6.22	7.98
Diluted EPS Before Extra, 1 Yr. Growth %	-31.49	35.41	-18.78	-30.3	83
Accounts Receivable, 1 Yr. Growth %	21.8	16.11	4.43	37.91	18.55
Inventory, 1 Yr. Growth %	17.6	28.34	18.17	18.55	9.65
Net Property, Plant and Equip., 1 Yr. Growth %	-4.59	-21.82	-4.15	-5.59	5.92
Total Assets, 1 Yr. Growth %	-0.36	-7.07	6.17	2.04	1.31
Tangible Book Value, 1 Yr. Growth %	8.57	1.88	-12.84	12.18	-2.91
Common Equity, 1 Yr. Growth %	-6.38	-4.75	3.46	-11.23	1.66
Cash From Operations, 1 Yr. Growth %	-30.52	20.37	36.47	-12.27	-7.35
Capital Expenditures, 1 Yr. Growth %	5.48	12.22	21.47	-10.62	-13.8
Levered Free Cash Flow, 1 Yr. Growth %	-92.34	1K	-15.99	-58.49	160.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-87.61	580.97	-13.65	-52.69	127.14
Dividend Per Share, 1 Yr. Growth %	9.9K	12	9.82	13.82	7.86
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.47	6.09	5.91	17	18.65
Gross Profit, 2 Yr. CAGR %	-4.31	-1.52	4.74	5.11	0.76
EBITDA, 2 Yr. CAGR %	-7.28	-0.16	4.12	4.73	5.39
EBITA, 2 Yr. CAGR %	-7.32	-0.04	4.19	4.86	5.61
EBIT, 2 Yr. CAGR %	-3.81	-0.51	4.94	6.29	6.56
Earnings From Cont. Operations, 2 Yr. CAGR %	2.84	-10.86	-0.44	-25.36	8.19
Net Income, 2 Yr. CAGR %	2.52	-11.21	-1.94	-28.43	7.4
Normalized Net Income, 2 Yr. CAGR %	-1.56	0.3	2.08	3.27	7.1
Diluted EPS Before Extra, 2 Yr. CAGR %	8.18	-3.68	5.08	-24.76	12.94
Accounts Receivable, 2 Yr. CAGR %	18.65	18.92	10.12	19.08	27.86
Inventory, 2 Yr. CAGR %	18.27	22.85	23.15	18.36	14.01
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.54	-13.63	-13.43	-20.22	0
Total Assets, 2 Yr. CAGR %	-0.28	-3.78	-0.69	4.09	1.67
Tangible Book Value, 2 Yr. CAGR %	-4.89	5.62	-5.51	-1.24	4.36
Common Equity, 2 Yr. CAGR %	1.94	-5.57	-0.95	-4.16	-5
Cash From Operations, 2 Yr. CAGR %	-12.93	-8.55	28.17	9.42	-9.85
Capital Expenditures, 2 Yr. CAGR %	4.84	8.8	16.75	4.2	-12.22
Levered Free Cash Flow, 2 Yr. CAGR %	-44.9	-8.16	203.83	-40.38	4.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	-36.9	-8.14	142.4	-35.76	3.66
Dividend Per Share, 2 Yr. CAGR %	900	958.3	10.91	11.8	10.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	52.95	5.54	6.78	12.39	15.05
Gross Profit, 3 Yr. CAGR %	12.04	-2.18	1.32	4.2	2.84
EBITDA, 3 Yr. CAGR %	24.02	-3.73	1.37	4.73	4.9
EBITA, 3 Yr. CAGR %	24.13	-3.72	1.46	4.87	5.05
EBIT, 3 Yr. CAGR %	18.8	-1.29	1.62	5.89	6.14
Earnings From Cont. Operations, 3 Yr. CAGR %	26.96	9.63	-14.15	-11.33	-2.49
Net Income, 3 Yr. CAGR %	26.71	9.32	-15.17	-13.85	-3.86
Normalized Net Income, 3 Yr. CAGR %	14.39	0.05	0.5	3.44	4.82
Diluted EPS Before Extra, 3 Yr. CAGR %	14.28	16.59	-8.85	-8.36	1.18
Accounts Receivable, 3 Yr. CAGR %	12.75	17.8	13.88	18.09	18.91
Inventory, 3 Yr. CAGR %	9.68	21.54	21.27	21.6	15.38
Net Property, Plant and Equip., 3 Yr. CAGR %	9.05	-9.44	-10.58	-20.76	-12.32
Total Assets, 3 Yr. CAGR %	0.36	-2.6	-0.58	0.21	3.15
Tangible Book Value, 3 Yr. CAGR %	-8.28	-2.4	-0.75	-0.03	-1.8
Common Equity, 3 Yr. CAGR %	4.72	-0.34	-2.79	-4.5	-2.26
Cash From Operations, 3 Yr. CAGR %	24.02	-3	4.51	12.95	3.51
Capital Expenditures, 3 Yr. CAGR %	29.77	7.24	12.87	6.81	-2.18
Levered Free Cash Flow, 3 Yr. CAGR %	-55.78	49.54	-10.8	57.26	-2.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	-47.13	39.44	-9.97	41.24	-2.14
Dividend Per Share, 3 Yr. CAGR %	364.16	382.03	397.32	11.87	10.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	34.3	33.98	32.04	9.98	11.38
Gross Profit, 5 Yr. CAGR %	12	10.75	9.05	0.7	1.09
EBITDA, 5 Yr. CAGR %	22.98	18.75	15.65	-0.24	3.05
EBITA, 5 Yr. CAGR %	23.48	19.02	15.74	-0.18	3.19
EBIT, 5 Yr. CAGR %	20.19	15.49	13.07	1.92	3.68
Earnings From Cont. Operations, 5 Yr. CAGR %	24.06	24.76	15.22	-5.9	-5.83
Net Income, 5 Yr. CAGR %	23.51	24.41	14.39	-7.62	-6.77
Normalized Net Income, 5 Yr. CAGR %	18.22	12.71	9.32	1.43	3.09
Diluted EPS Before Extra, 5 Yr. CAGR %	16.95	19.42	10.53	-2.05	-0.69
Accounts Receivable, 5 Yr. CAGR %	37.03	42.34	11.69	18.31	18.91
Inventory, 5 Yr. CAGR %	-	83.76	14.88	20.25	18.32
Net Property, Plant and Equip., 5 Yr. CAGR %	16.75	11.47	-0.57	-13.92	-12.85
Total Assets, 5 Yr. CAGR %	21.14	18.44	-0.06	0.01	0.32
Tangible Book Value, 5 Yr. CAGR %	40.06	41.5	-7.02	-1.83	1.22
Common Equity, 5 Yr. CAGR %	27.98	26.76	2.41	-1.98	-3.68
Cash From Operations, 5 Yr. CAGR %	12.3	16.2	25.66	1.79	-1.49
Capital Expenditures, 5 Yr. CAGR %	20.14	22.42	24.4	6.01	2.07
Levered Free Cash Flow, 5 Yr. CAGR %	-31.38	-0.56	-4.34	3.46	-4.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	-23.86	0.56	-2.74	2.37	-4.49
Dividend Per Share, 5 Yr. CAGR %	151.19	156.95	161.81	168.67	172.77